Who owns LIPOCINE INC NEW?

Tip: Access positions for across all investors

Analyze quarterly positions in Lipocine with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Lipocine stock

Who bought or sold LIPOCINE INC NEW this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Diadema Partners 261k $2.1M 100% Dec 2025
 View chart
Vanguard Group 222k $1.8M 0% Dec 2025
 View chart
Ikarian Capital 200k $1.6M 100% Dec 2025
 View chart
BlackRock 89k $717k 0% Dec 2025
 View chart
Persistent Asset Partners 71k $567k 100% Dec 2025
 View chart
Geode Capital Management 63k $502k 2% Dec 2025
 View chart
Boothbay Fund Management 55k $441k 100% Dec 2025
 View chart
Renaissance Technologies 37k $300k 4% Dec 2025
 View chart
Susquehanna International 25k $200k -47% Dec 2025
 View chart
State Street Corporation 19k $150k 0% Dec 2025
 View chart
Ameriprise Financial 16k $129k 100% Dec 2025
 View chart
Citadel Advisors 14k $41k 100% Sep 2025
 View chart
Northern Trust 13k $106k 0% Dec 2025
 View chart
Dimensional Fund Advisors 12k $98k 0% Dec 2025
 View chart
Jane Street 11k $85k 100% Dec 2025
 View chart
UBS Group 5.6k $45k 217% Dec 2025
 View chart
Caldwell Sutter Capital 471.00 $3.8k 0% Dec 2025
 View chart
Group One Trading 162.00 $1.3k 0% Dec 2025
 View chart
Advisor Group Holdings 118.00 $946.997200 -95% Dec 2025
 View chart
HighMark Wealth Management 100.00 $803.000000 100% Dec 2025
 View chart
SBI Securities 67.00 $538.003300 0% Dec 2025
 View chart
Tidemark 59.00 $474.000100 0% Dec 2025
 View chart
FMR 59.00 $168.999600 100% Sep 2025
 View chart
Royal Bank of Canada 1.00 $0 100% Sep 2025
 View chart

Who sold out of Lipocine?

Fund or Company Name Date Sold Shares Held Valued At
Barclays Sep 2025 9.4k $27k
Tower Research Capital Sep 2025 1.2k $3.3k